OPGN Stock Price, Chart, Stats & News

OpGen, Inc.
Save
OpGen, Inc. (OPGN) does not currently pay a dividend.
242.67M
Market cap
132.83x
Current P/E
–
Forward P/E
OPGN chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Diagnostics & Research
Industry
OpGen, Inc. is a precision medicine company dedicated to developing and commercializing advanced molecular microbiology solutions for both U. S. and international markets. Its comprehensive product suite includes the Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test designed to pinpoint various bacterial nucleic acids and genetic markers of antimicrobial resistance (AMR) from bacterial colonies sourced from diverse specimen types.
Similar securities
Based on sector and market capitalization
Report issue





